Arca

Pharma markets this week

Oct 19 to Oct 25, 2026

1 acquisition, 5 funding rounds, 5 officer changes.

Acquisitions 1

Every acquisition since 2016

Personalis, Inc. · Tempus AI, Inc.

Tempus AI, Inc. to buy Personalis, Inc. for $1.7B

2026-10-21 · Pending · cash and stock · Tools and diagnostics · $16.25 per share · Value from price × shares

Source

Funding rounds of $5 million or more, and IPOs 5

Funding rounds

Officer and director changes 5

Lunai Bioworks Inc.

Change in directors or officers

2026-10-23 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source

CytoDyn Inc.

Change in directors or officers

2026-10-19 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source

iBio, Inc.

Change in directors or officers

2026-10-19 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source